Dongwha Pharm.Co.Ltd (000020) — Capital Reinvestment Ratio
Dongwha Pharm.Co.Ltd (000020) has a Capital Reinvestment Ratio of 5.32x as of March 2026, meaning it reinvests 5% of its operating cash flow (₩697.02 Million) in capital expenditures (₩3.71 Billion). Check how tangible is Dongwha Pharm.Co.Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dongwha Pharm.Co.Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Dongwha Pharm.Co.Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see Dongwha Pharm.Co.Ltd (000020) cash flow conversion.
Annual Capital Reinvestment Ratio for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Dongwha Pharm.Co.Ltd from 2011 to 2025. See Dongwha Pharm.Co.Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.52x | ₩15.70 Billion | ₩55.30 Billion | ▲ +290.0% |
| 2023 | 0.90x | ₩29.17 Billion | ₩26.35 Billion | ▲ +43.2% |
| 2022 | 0.63x | ₩29.22 Billion | ₩18.43 Billion | ▲ +3.6% |
| 2021 | 0.61x | ₩36.03 Billion | ₩21.94 Billion | ▼ -7.1% |
| 2020 | 0.66x | ₩52.23 Billion | ₩34.25 Billion | ▲ +81.6% |
| 2019 | 0.36x | ₩13.28 Billion | ₩4.80 Billion | ▲ +267.6% |
| 2016 | 0.10x | ₩25.48 Billion | ₩2.50 Billion | ▲ +120.0% |
| 2015 | 0.04x | ₩19.83 Billion | ₩885.50 Million | ▼ -52.7% |
| 2014 | 0.09x | ₩13.51 Billion | ₩1.28 Billion | ▼ -76.1% |
| 2013 | 0.40x | ₩8.21 Billion | ₩3.24 Billion | ▲ +53.9% |
| 2012 | 0.26x | ₩25.23 Billion | ₩6.48 Billion | ▲ +29.9% |
| 2011 | 0.20x | ₩46.24 Billion | ₩9.15 Billion | — |